Abiopharma

🔍 Kayyem Jon Faiz (Executive)

Company: BIODESIX INC (BDSX)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 5,443 shares of Restricted Stock Units (Derivative)
  Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,443.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2, F3
• Acquired 6,354 shares of Stock Options (Right to Buy) at $6.46 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-01 | equity_swap_involved: 0 | shares_owned_after: 6,354.00 | transaction_form_type: 4 | Footnotes: F4

Footnotes:

• F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock ("Common Stock").
• F2: These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
• F3: Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer.
• F4: This option vests in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer.